Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Urology · Renji Hospital · Shanghai

Dr. Dong Baijun董柏君

Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Dong Baijun

Professional overview

Dr. Dong Baijun is a Chief Physician in the Department of Urology at Renji Hospital (East Campus), specializing in urologic oncology—particularly prostate cancer diagnosis, treatment, and research.

SpecialtyUrology
Clinical titleChief Physician
Academic rolesMaster's Supervisor
DepartmentDepartment of Urology
HospitalRenji Hospital
CityShanghai
CampusEast Campus

Areas of focus

Prostate cancer
Renal cell carcinoma
Bladder cancer

Background

  • 2017Received Shanghai Talent Development Fund support.
  • 2019Received Research-oriented Physician Support under the Shanghai Municipal Education Commission Peak and Plateau Discipline Construction Program.
  • 2021Recognized as an Outstanding MDT Physician by the Chinese Anti-Cancer Association Urogenital Cancer Committee.
  • 2022Recognized as an Outstanding MDT Physician by the Chinese Anti-Cancer Association Urogenital Cancer Committee.

Experience & recognition

  • Shanghai Medical Association Urology Branch '2019 Young Talent'
  • 2020 'People's Good Doctor (Urologic Oncology Field) Golden Camellia – Outstanding Contribution' award, China Cancer Prevention Annual Conference
  • First or corresponding author of over 50 SCI-indexed publications
  • Contributor to 8 Chinese expert consensus documents on prostate cancer management, including the CSCO Prostate Cancer Guidelines 2020 and the Guidelines for Diagnosis and Treatment of Urological and Andrological Diseases (2019 Edition)

Professional roles

  • Member, Prostate Cancer Expert Committee, Chinese Society of Clinical Oncology (CSCO)
  • Member, Basic Research Working Group, Chinese Urological Association (CUA)
  • Member, Prostate Cancer Working Group, Urogenital Cancer Committee, China Anti-Cancer Association (CACA)
  • Standing Committee Member, Tumor Multidisciplinary Diagnosis Collaboration Group, Tumor Biomarkers Committee, China Anti-Cancer Association (CACA)
  • Member, Interventional Ablation Expert Committee, China Anti-Cancer Association (CACA)
  • Communications Editor, Chinese Journal of Urology

Frequently asked questions

What does Dr. Dong Baijun specialize in?

Specializes in urologic oncology—particularly prostate cancer clinical diagnosis and treatment, including precision biopsy, robot-assisted or laparoscopic nerve-sparing surgery, cryoablation/HIFU/nanoknife ablation, molecular diagnosis, precision therapy, individualized treatment for castration-resistant disease, and comprehensive management of neuroendocrine differentiated prostate cancer; also performs precision diagnosis and treatment of renal cell carcinoma and bladder cancer.

Which hospital and department is Dr. Dong Baijun in?

Department of Urology at Renji Hospital (East Campus)

Sources

Dr. Dong Baijun has not reviewed this page. Request a correction or removal.